8-K current report · filed Oct 5, 2026

C.H. Robinson (CHRW) 8-K Current Report: October 5, 2026

Item 1.01Item 7.01Item 5.02Item EX-99.1Item EX-99.2CHRW overview

Short answer

C.H. Robinson (CHRW) filed an 8-K current report with the SEC on October 5, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), Item 5.02 (Departure/Election of Directors or Officers), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2). Proposed RXO acquisition, expected closing first half 2027, subject to RXO shareholder and regulatory approvals.

C.H. Robinson 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.01 · Entry into a Material Definitive Agreement

  • Proposed RXO acquisition, expected closing first half 2027, subject to RXO shareholder and regulatory approvals
  • RXO holders may receive $17.25 cash plus 0.0856 CHRW shares, $30.25 cash, or 0.1992 CHRW shares, subject to proration
  • $4.5 billion, 364-day bridge facility supports cash consideration, RXO debt refinancing, fees, and credit amendments
  • Financing is not a closing condition, with CHRW targeting capital markets debt, term loans, and cash before bridge borrowings
  • RXO shareholder owning 17.04% committed to vote for the transaction, while RXO faces a $175 million termination fee under specified circumstances

Item 5.02 · Departure/Election of Directors or Officers

  • Filing concerns RXO executive and director disclosures, not a clearly identified CHRW officer departure or election
  • Investor and shareholder interests addressed through RXO proxy, 2025 Form 10-K, and Forms 3, 4, and 5
  • Proposed transaction materials, including proxy statement/prospectus, remain important for voting and investment decisions
  • Filing includes no-offer language and directs investors to future SEC materials for transaction details

Item 7.01 · Regulation FD Disclosure

  • C.H. Robinson and RXO jointly issued a transaction-related press release on October 5, 2026
  • Investor presentation released, providing additional transaction rationale and terms
  • Market impact depends on transaction details in Exhibits 99.1 and 99.2

Item EX-99.1 · Exhibit EX-99.1

  • Proposed $5.8B acquisition of RXO, creating a combined company with enterprise value exceeding $25B
  • RXO holders receive $17.25 cash plus 0.0856 CHRW shares, implying $30.25 per share and a 27% premium
  • Expected $300M net run-rate cost synergies within two years, primarily from Lean AI productivity improvements
  • Adjusted EPS accretion expected within nine months, reaching mid-teens accretion in 2028
  • Transaction targeted for first half of 2027, financed with new debt and expected to pause share repurchases until leverage reaches 1.75x to 2.25x

Item EX-99.2 · Exhibit EX-99.2

  • C.H. Robinson plans to acquire 100% of RXO for $5.8B enterprise value, combining two major North American logistics platforms
  • Consideration includes $17.25 cash plus 0.0856 C.H. Robinson shares per RXO share, implying $30.25 per RXO share
  • ~$300M estimated net run-rate cost synergies targeted within two years, with adjusted EPS accretion expected within 9 months
  • Transaction financing includes $4.5B committed backup financing, while share repurchases pause and leverage targets 1.75x–2.25x by year-end 2028
  • Closing expected in the first half of 2027, requiring regulatory and RXO shareholder approvals

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other C.H. Robinson 8-K filings

Get the next CHRW 8-K as it lands

Follow CHRW for push alerts, or ask the research agent what this filing means.